Actively Recruiting
Study of Lipid Mediators in Chronic Postoperative Pain - LICP
Led by Université Catholique de Louvain · Updated on 2025-04-02
300
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
Sponsors
U
Université Catholique de Louvain
Lead Sponsor
C
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborating Sponsor
AI-Summary
What this Trial Is About
This interventional prospective study aims firstly to investigate variations in lipid levels in blood samples and their potential relationship with the duration and/or intensity of post-operative pain. Secondly, it aims to investigate the activation of peripheral blood mononuclear cells and neutrophils in patient blood samples. The study will enrol women aged 18 years or older who have been newly diagnosed with primary invasive or non-invasive breast cancer requiring surgical removal of the tumour, with or without axillary surgery. The main objectives of the study are To assess whether there is an association between circulating levels of lipid mediators and chronicity (\> 3 months) of postoperative pain after breast cancer surgery. To assess whether circulating levels of lipid mediators can predict chronicity of postoperative pain in breast cancer surgery. To assess the existence of an association between resected tissue levels of lipid mediators and chronicity of postoperative pain in breast cancer surgery. To assess whether tissue levels of lipid mediators can predict chronicity of postoperative pain in breast cancer surgery.
CONDITIONS
Official Title
Study of Lipid Mediators in Chronic Postoperative Pain - LICP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women older than 18 years
- Newly diagnosed primary invasive or non-invasive breast cancer requiring surgical removal of the tumor, with or without axillary surgery
- Able to give informed consent
You will not qualify if you...
- Men
- Women younger than 18 years
- Pregnant women
- History of major psychiatric disorders
- Previous breast or axillary surgery, recurrent disease, or detectable metastatic disease at diagnosis
- Unable to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cliniques universitaires Saint-Luc (UCLouvain)
Brussels, Brussels Capital, Belgium, 1200
Actively Recruiting
Research Team
M
Martine Berlière, MD, PhD
CONTACT
L
Lisa Martin, MSC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here